CDKN1A and ovarian cancer: Interestingly, there was a remarkably high coexpression rate (80.6%) between P21WAF1/CIP1 and MDM2 in serous borderline ovarian tumors compared to both benign and malignant ovarian tumors, as well as mucinous borderline tumors (Palazzo et al., 2000).